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Abstract
Background: MicroRNAs (miRNAs) are an abundant class of small noncoding RNAs (20-24 nts) that can affect gene 
expression by post-transcriptional regulation of mRNAs. They play important roles in several biological processes (e.g., 
development and cell cycle regulation). Numerous bioinformatics methods have been developed to identify the 
function of miRNAs by predicting their target mRNAs. Some viral organisms also encode miRNAs, a fact that 
contributes to the complex interactions between viruses and their hosts. A need arises to understand the functional 
relationship between viral and host miRNAs and their effect on viral and host genes. Our approach to meet this 
challenge is to identify modules where viral and host miRNAs cooperatively regulate host gene expression.
Results: We present a method to identify groups of viral and host miRNAs that cooperate in post-transcriptional gene 
regulation, and their target genes that are involved in similar biological processes. We call these groups (genes and 
miRNAs of human and viral origin) - modules. The modules are found in a new two-stage procedure, which we call bi-
targeting, and is presented in this paper. The stages are (i) a new and efficient target prediction, and (ii) a new method 
for clustering objects of three different data types. In this work we integrate multiple information sources, including 
miRNA-target binding information, miRNA expression profiles, and GO annotations. Our hypotheses and the methods 
have been tested on human and Epstein Barr virus (EBV) miRNAs and human genes, for which we found 34 modules. 
We provide supporting evidence from biological and medical literature for two of our modules. Our code and data are 
available at http://www.cs.bgu.ac.il/~vaksler/BiTargeting.htm
Conclusions: The presented algorithm, which makes use of diverse biological data, is demonstrated to be an efficient 
approach for finding bi-targeting modules of viral and human miRNAs. These modules can contribute to a better 
understanding of viral-host interactions and the role that miRNAs play in them.
Background
MicroRNAs (miRNAs) are an abundant class of small
noncoding RNAs (20-24 nts) that can affect gene expres-
sion by post-transcriptional regulation of mRNAs [1].
They typically base pair with sequences in the 3' UTR of
mRNAs to inhibit mRNA translation or to promote their
degradation. miRNAs have been shown to play important
roles in various cellular and pathogenic processes, includ-
ing development, cell death, immunological response,
and carcinogenesis [2,3]. Since the functional character-
ization of miRNAs depends heavily on identification of
their specific target mRNAs, numerous bioinformatics
methods have been developed for this task (see e.g., [4-
11], for a review see [12-14]).
In recent years, it has been shown that viruses also
encode miRNAs [15,16]. Although for most of the viral
miRNAs no functions have yet been described, it is con-
jectured that these miRNAs also take part in the complex
interactions between viruses and their hosts, and several
scenarios have been proposed [17] (see Figure 1, where
scenario numbers are written in rhombi). In the first sce-
nario, viral miRNAs regulate viral gene expression for
maintaining, e.g., replication, latency, or evading the
host-immune system. For example, miR-BART2 of EBV
exhibits perfect complementarity to the 3'UTR of BALF5,
which encodes the viral DNA polymerase [18], and such
an interaction might be essential for maintaining EBV
latency. In the second scenario, host miRNAs interact
with viral RNAs, thereby inhibiting virus replication, e.g.,
miR-32 can limit the replication of the retrovirus primate
foamy virus (PFV) in cell culture through an interaction
with PFV mRNAs [19]. In the third scenario, viral miR-
NAs regulate host genes to induce a more favorable envi-
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Page 2 of 17ronment for the virus. The regulated genes are most
likely related to antiviral response, apoptosis, interferon
system, signal transduction, or cellular proliferation
[20,21]. Stern-Ginossar et al. [22] showed that human
cytomegalovirus (HCMV) miRNA, miR-UL112, inhibits
the translation of a cellular gene MICB, which is normally
activated when cells are subjected to severe stress, such as
viral infection. MICB marks these cells for destruction by
natural killer cells. The resulting absence of MICB pro-
tein protects HCMV-infected cells against lysis by natural
killer cells.
Viruses may affect host miRNAs for their own advan-
tage, by regulating up or down the expression of these
miRNAs. This happens in the fourth scenario reported in
[23]. In their research, host miR-17 and miR-20a were
found to be downregulated following human immunode-
ficiency virus (HIV-1) infection. These miRNAs target
the 3'UTR of host gene PCAF, which has been proposed
to promote HIV-1 transcriptional elongation. Hence, this
downregulation is needed for efficient replication of the
virus.
In our work we will examine the combination of the last
two scenarios, assuming that both human and viral miR-
NAs play an active role in regulating genes that either
promote or inhibit viral replication or life cycle.
Cooperativity of miRNAs in gene regulation
Previous studies show that one miRNA may have several
target genes. Furthermore, one mRNA can be targeted by
multiple miRNAs, reflecting cooperative translational
control [5,24,25]. Experimental evidence indicates that
multiple target sites (of one or more miRNAs) in the
same 3'UTR can potentially increase the degree of trans-
lational repression [9]. In addition, microarray analyses
[26] reveal that most of the miRNAs only modestly affect
their mRNA targets. Recent findings show that some
virus encoded miRNAs have sequence homology to their
host human/mouse miRNAs, mainly in the seed region
(see review [21]). This is one of many mechanisms that
are used by viruses to exploit their host [27-30]. We were
intrigued by an additional possibility in which viral and
host encoded miRNAs target the same mRNA, possibly
in different target sites, to promote gene silencing. It
Figure 1 Four scenarios for miRNA involvement in host-virus interactions. (1) Viral miRNAs inhibit the expression of viral mRNAs. (2) Host miRNAs 
inhibit the expression of viral mRNAs. (3) Viral miRNAs inhibit the expression of host mRNAs. (4) Host miRNAs inhibit the expression of host mRNAs. In 
this case, viruses may regulate host miRNA expression and indirectly regulate host gene expression. (This figure is partially adapted from [81].)
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with human miRNAs may contribute to increasing the
translational repression and tighten the regulation which
already exists at a low level in the cell (by the host regula-
tion machinery). This important question motivated us
to study and predict the cooperativity of viral and host
miRNAs on host genes.
In this paper, we present a new computational method
for examining cooperative effects of viral and host miR-
NAs on the regulation of host genes. We find modules
consisting of both viral and human miRNAs, and their
common target genes, that are involved in similar biolog-
ical processes (according to GO). The mathematical for-
mulation of our problem is an extension of a related
problem, where the sought modules consist of miRNAs
and genes of the same species. Below we present some
studies that worked to solve the latter problem. Yoon and
De Micheli [31], the first to address that problem, repre-
sent the multiple relations between miRNAs and target
genes by a weighted bipartite graph, and find bi-cliques in
the graph that represent the miRNA-mRNA modules
(see Figure 2). They predict modules using target predic-
tion based on sequence information.
Two other approaches combine several information
sources to extract the modules, including predictions of
miRNA target genes and their respective expression pro-
files. Joung et al. [32] apply a genetic algorithm, based on
coevolutionary learning, to find an optimal miRNA-
mRNA module. Tran et al. [33] use a rule-based learning
method to identify the modules.
In general, finding bi-cliques in bi-partite graphs can be
formulated as a bi-clustering problem (reviewed in [34]),
which is known to be NP-complete. Therefore, most of
the methods that address bi-clustering are based on heu-
ristic approaches, which may miss good solutions. Alter-
natively, applying naive exhaustive enumeration to this
problem is extremely time consuming to the point of
being impractical. The problem becomes even more
complicated when searching for cooperative human-viral
miRNA modules. Directly applying one of the existing bi-
clustering algorithms to a united set of both human and
viral miRNAs may be insensitive to the contribution of
viral miRNAs. This is due to the wide imbalance between
the numbers of human miRNAs and viral miRNAs (hun-
dreds of human miRNAs versus tens of viral miRNAs
identified to date).
In order to be able to control the composition of the
sought modules in terms of viral and human miRNA par-
ticipants, a new type of clustering algorithm is needed.
And indeed, in this paper we describe a bi-targeting algo-
rithm which we developed (see Methods). We apply a
branch and bound approach to develop and prune an
enumeration tree of groups of human genes that are tar-
geted by the same set of viral and human miRNAs. This
algorithm is very efficient since we exploit the fact that
the number of known viral miRNAs is relatively small,
and that we demand a quorum on the number of miRNAs
in the modules (a minimum number of viral and human
miRNAs). This "pruning by quorum" allows us to apply
enumeration in practical run time. We implemented our
bi-targeting algorithm into a software system that com-
bines a variety of biological data sources, such as:
genomic sequences, miRNA expression measurements,
GO annotations, and tissue context. The combination of
several information sources in the task of module detec-
tion minimizes noise and errors accompanying each
information source, resulting in more accurate results.
In addition, we developed a very flexible and efficient
target prediction algorithm, which we briefly describe in
the next section, and in more detail in the Appendix Sec-
tion. We use it as a preprocessing step to the module
search.
Using the bi-targeting system, we study the cooperative
regulation of human and Epstein Barr Virus (EBV) miR-
NAs on human mRNAs in various lymphomas related to
EBV. The significant modules are picked by a sampling
procedure (described in the next section). We validate
two of these modules by surveying information from the
biological and biomedical literature. The rest of the sig-
nificant modules can be found at http://www.cs.bgu.ac.il/
~vaksler/BiTargeting.htm.
We believe that the results of this research may have
far-reaching implications, as they may be applied to the
diagnosis and treatment of viral infections, as well as for a
wider understanding of viral-induced diseases and the
role that miRNAs plays in them. Our study can contrib-
ute to the discovery of genes that regulate virus-host
interactions, especially, but not only, in chronic infec-
tions, and can serve as targets for therapy [35,36].
Figure 2 Bipartite graph. Bi-cliques in the graph are circled.
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Our method consists of two stages: a target prediction
stage and a module search stage. In the first stage, we per-
form all against all dynamic programming on two sets of
sequences (miRNAs and mRNAs) in order to predict, for
every miRNA in the set, its target mRNAs. In the second
stage we look for modules that are enriched in some bio-
logical process, using the results from the first stage and
information from Gene Ontology and the miRNA Atlas.
We elaborate more on the second stage since this is the
main goal of our paper. The interested reader may find a
description of the first stage in the Appendix Section.
Stage 1 - Predicting microRNA targets
The purpose of this stage is to perform an efficient
genome-wide target prediction of all the miRNAs against
all the possible subsequences of a set of mRNAs. miRNA
target prediction is a well-studied problem, with numer-
ous tools and approaches available. Each of these tools
accommodates a variety of principles and features of tar-
get recognition, for example typical base pairing patterns,
thermodynamic analysis of the miRNA-target duplexes,
conservation of the target site among related species, and
accessibility of the target site. For a review see [13,14].
The amount of the data we need to analyze is huge
(thousands of genes and hundreds of miRNAs) and thus
applying existing tools to this analysis would be too time
consuming. Hence, we developed our own efficient tool
for this task (which can serve as a plug-in filter to other
target prediction tools). The method we propose extends
the threshold all-against-all sequence alignment algo-
rithm [37,38].
We store the miRNA sequences in a prefix tree (trie)
and the mRNA sequences in a separate prefix tree (for
details see the Appendix Section). We then apply
dynamic programming to compute hybridization error
between a prefix from the mRNA tree and a prefix from
the miRNA tree, for each such pair. If, in one comparison,
the number of errors we encounter is larger than a given
threshold, then we stop comparing this pair and its
descendants in the respective trees (prune the subtrees).
Those miRNA-target pairs that survived the error thresh-
old can be further checked for duplex energy by the RNA-
duplex program [39]. This results in linking each miRNA
in our data set to its predicted target genes.
This method is efficient since it simultaneously checks
sets of mRNA sequences (and, respectively, miRNA
sequences) that share a prefix in the mRNA (respectively,
miRNA) prefix trees. Moreover, it goes over all the
duplexes, and prunes those with a hybridization error
above a threshold, allowing a very efficient filtration.
Comparison with existing approaches
We compare our target prediction method with three
existing tools (those that provide downloadable code).
The tools are miRanda [5], PITA [40] and RNAhybrid
[10]. Our dataset consists of 873 experimentally validated
miRNA-gene pairs out of 99 human miRNAs and 640
mRNAs (from miRecords [41]). We downloaded the
3'UTR sequences of these mRNAs from Ensembl
Biomart [42], a total of 2183 different transcript
sequences. In our results, an miRNA-mRNA pair is con-
sidered a hit if the miRNA is found to target one of the
transcripts of the mRNA. We ran our target prediction
method with the constraints listed in Table 1. miRanda
was run with default parameters. The parameters of PITA
and RNAhybrid were set to be close to ours (seed 2-8, and
the maximal bulge size, in RNAhybrid was set to 6). We
compare the results of these four methods in Table 2. The
information which we compare includes: the total num-
ber of predicted pairs, the number of TP predicted pairs
(sensitivity) and the running time. For our target predic-
tion tool, the total number of predicted pairs falls within
the ballpark of both PITA and miRanda. RNAhybrid, on
the other hand, predicts twice as many pairs. As far as
sensitivity goes, our results pretty much match that of
PITA and outperforms miRanda by far. RNAhybrid gave
the best sensitivity, (however this comes at the cost of a
very high number of total predicted pairs). When com-
paring running times, our tool noticeably outperformed
all the other engines, this in spite of keeping up competi-
tive sensitivity and total number of predicted pairs. Recall
that fast running time was the main objective for devel-
oping our fast filtration.
Stage 2 - Finding modules - the enumeration algorithm
In this section we describe our enumeration algorithm
for finding modules that are statistically enriched in bio-
logical processes (GO categories). An important objec-
tive in our study is to ensure that the modules found by
our method contain miRNAs that are mutually expressed
and thus can cooperatively regulate gene expression. In
order to ensure this condition, we use the miRNA Atlas
[43]. This Atlas provides miRNA expression profiles in
Table 1: Constraint parameters for the target prediction 
algorithm.
seed location 2-8
maximum GU pairs in seed 1
maximum GU pairs total 4
maximal number of mismatches/gaps 6
maximal size of bulge in the target 6
maximal size of bulge in miRNA 6
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types, of normal and malignant tissues). We focus on a set
of conditions where both human and viral miRNAs (of
the virus of interest) are expressed. Based on these data
sources, we address the following problem.
Given a GO category C, a miRNA atlas condition A,
expression level threshold t, a p-value threshold p, the
minimal number of human and viral miRNAs required in
a sought module q1 and q2 (the quorums), respectively.
Find all the modules composed of miRNAs whose expres-
sion in A is greater than t, which include at least q1 and q2
human and viral miRNAs, respectively, and whose inter-
section of the target-sets of human genes yields an enrich-
ment p-value smaller than p in C.
The enrichment is measured using a hypergeometric p-
value [44]. The hypergeometric p-value measures the sta-
tistical significance of the overlap between the target
genes and the genes in the considered category (for more
details see the Appendix Section).
For each GO category C and each Atlas condition A of
interest, we perform the enumeration process as follows.
Let H and V be the set of human and viral miRNAs. Let
HA and VA be the subset of human and viral miRNAs
expressed in A. Let TA be the set of their target genes
(each gene in TA is targeted by at least q1 human and q2
viral miRNAs); and let TCA = TA ( C (see Figure 3).
Our enumeration algorithm dynamically constructs
and prunes an enumeration tree, which is built from the
genes in TCA. A path in the tree represents a potential
module. The module consists of the genes in the inner
nodes of the path and a list of miRNAs (which target all
these genes) in the leaf (see, e.g., Figures 4 and 5). At the
end of the run of the algorithm, the enumeration tree
stores in its leaves all the modules that satisfy the quorum
constraints. The pseudocode of our algorithm is found in
the Appendix Section. Below we supply an illustration of
the algorithm applied on the data from Table 3, with the
quorum constraints q1 = 2 and q2 = 1. We initialize the
tree to consist of a root node and one dummy leaf node
with all the human and viral miRNAs in A (see the left-
most leaf in Figure 4(a)). Genes are inserted to the tree
one by one in order of increasing number of hits of
human miRNAs on the gene (b, c, d, a). Each inserted
gene, g, is connected by an edge to the root and becomes
a root of newly generated copies of all its preceding sib-
lings in the tree. The leaves of the new subtree contain
intersections of g's miRNA sets (human and viral) with
the corresponding sets in the siblings' leaves. When these
intersections do not satisfy the quorum constraints we
prune the unsatisfying edge from the tree. (See the node
for gene b, and then for gene c, in Figure 4(a). The leaves
of the subtree rooted at c contain the intersections of the
set of miRNAs hitting c with the set of the dummy leaf,
and of b. Notice that the respective intersections of the
miRNA sets hitting b and c are empty. Thus the edge
from c to b is pruned from the tree).
Figure 3 An illustration of the connection between Atlas condi-
tion and GO category. H is all the known human miRNAs and V is all 
known viral miRNAs. HA (VA) are the human (viral) miRNAs expressed in 
Atlas category A. They target gene set TA. TCA consists of the targets of 
TA that belong to GO category C.
Table 2: A comparison between our method and other target prediction tools.





miRanda 22,857 309 35% 2 hours and 42 minutess
PITA 28,032 661 75% 5 hours and 10 minutess
RNA hybrid 43,693 731 83% 31 minutes
Our method 24,571 625 71% 40 seconds
a Out of 63,360 pairs. b Out of 873 experimentally verified pairs.
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making it the root of all its preceding siblings: the dummy
node, b node, and c node. In the leaves of the subtree
rooted at d are the intersections of the respective miRNA
sets. Now two prunings occur in the enumeration tree.
The original node b (in the dotted rectangle) and its tar-
geting miRNAs, are now fully contained in the subtree
rooted in d, thus b is now redundant and deleted from the
enumeration tree. As in 4(a), the sets of miRNAs of c and
of d are both empty and the edge from d to c is pruned
(solid rectangle).
In Figure 4(c) we illustrate adding a, making it the root
of the subtrees of its siblings. Intersecting a's miRNA sets
with the siblings' miRNA sets, resulting in deleting c (dot-
ted rectangle) and pruning d (solid rectangle).
At the end of the process, the enumeration tree con-
tains all the modules (see Figure 5). The leaves of the tree
are traversed and their p-value is computed. The modules
are then filtered (see the sampling procedure below) and
reported according to ascending p-value.
The sampling procedure
To set a cutoff p-value for significant modules, we esti-
mate the distribution of the hyper-geometric p-value
scores for every <A, C> pair as follows. We sample, from
the full set of miRNAs, two subsets of human and viral
miRNAs, of same size as HA and VA, respectively. Then
we find their target genes that satisfy the quorums, and
intersect them with C. Next, we perform the enumeration
algorithm on the genes in the intersection and store the
hypergeometric p-values of the obtained modules. We
repeat this sampling process 10,000 times, and compute
the distribution of the obtained p-values. This distribu-
tion allows us to pick a significant p-value for our
reported modules. We pick the p-value that is in the 0.01
quantile of the distribution to be the p-value cutoff for
our reported modules.
Results
We applied our system to the discovery of modules of
genes targeted by human miRNAs and miRNAs of the
Epstein Barr Virus. The Epstein-Barr virus (EBV) is a
human herpes-virus that infects over 90% of the human
population worldwide. EBV can infect B lymphocytes and
epithelial cells, and typically establishes long-term
asymptomatic latent infection in memory B lymphocytes.
Nevertheless, EBV infection has oncogenic potential,
which can result in a number of malignancies, including
Burkitt's lymphoma, Hodgkin's lymphoma, nasopharyn-
Table 3: miRNA target information.
Genes
miRNAs









total human miRNAs 1,2,4,6 3,5 2,4,6 1,3,5
total viral miRNAs A B A B
The columns correspond to genes (in TCA) and the rows to human and viral miRNAs (HA and VA, respectively). Cell (M, G) in the table is checked 
if miRNA M is predicted to target gene G. The last row provides, for every gene, its targeting miRNAs (numbers and letters corresponding to 
human and viral miRNAs, respectively).
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Page 7 of 17geal carcinoma, and lymphoproliferative diseases, espe-
cially among immunocompromised individuals [45].
During the latent infection of EBV, only a limited subset
of its genes is transcribed, allowing it to evade immune
recognition.
Latency gene expression is classified into three groups:
type I - expressing only nuclear protein EBNA1; type II -
expression of EBNA1 and membrane proteins LMP-1,
2A, 2B; type III - six nuclear proteins EBNA-1, 2, 3A, 3B,
3C, LP, and three membrane proteins LMP-1, 2A, 2B.
The noncoding RNAs EBER1 and EBER2 and a set of
EBV-encoded miRNAs are differentially expressed in all
three forms of latency [46].
Datasets
The set of human and viral mature miRNA sequences
was downloaded from the miRNA registry [47] contain-
ing 866 human miRNAs and 39 EBV miRNAs (mature
sequences). The set of human 3'UTR sequences was
extracted from the Ensembl's Biomart [42], database
Ensembl 53. Each 3'UTR in this set is annotated with an
Ensembl gene and transcript ID.
The gene ontology (GO) associations and ontology
structure files were downloaded from [48]. Each 3'UTR
was attributed to the corresponding gene name in the
ontology file, using the Ensembl gene and transcipt IDs.
The set of 3'UTRs was filtered to contain 3' UTRs from
genes that are expressed in B cells (data taken from
Ensembl Biomart) and that have at least one biological
process annotation. This resulted in 7208 sequences (dif-
ferent transcripts) from 4773 genes. UTRs longer than
3000 nts, were shortened to 3000 nts. miRNA expressions
were taken from the miRNA Atlas. Eight tissue samples
from the Atlas, expressing both human and EBV miR-
NAs, were found to be relevant. Seventy-two GO catego-
ries (that contain 10-300 genes) related to apoptosis,
immune response, signal transduction, proliferation, and
cell cycle were chosen.
The target prediction stage
In the first stage we ran all-against-all target prediction
between the miRNA and 3'UTR sets described above.
The target prediction was carried out with the con-
straints listed in Table 1, which are derived from the liter-
ature (e.g. [12,22,49]). In addition we checked duplex
energy at the leaves of the prefix tree (see Methods). The
duplex energy was normalized by the energy of the
duplex formed between the miRNA and its complement,
and if the resulting ratio exceeded a threshold of 0.4 the
target prediction was accepted as positive.
Running the target prediction on 866 human miRNAs
(39 EBV miRNAs) and 7208 human mRNAs (3' UTRs)
Figure 4 The process of building the enumeration tree for target 
information in Table 3. The rhombus represents the root of the tree. 
The circles represent the genes inserted into the tree. The squares rep-
resent the leaves, which store two sets of miRNAs - human and viral. 
These miRNAs are common "targeters" to all the genes in the path 
from the leaf to the root. Viral miRNAs are labeled with uppercase let-
ters and the human miRNAs are labeled with numbers. The rectangles 
indicate modules that are pruned from the tree for one of two reasons: 
(1) modules that break the quorum are in solid rectangles (in this ex-
ample the required quorum is 1 viral miRNA and 2 human miRNAs); (2) 
redundant modules (which are fully contained in another module) are 
in dotted rectangles. The arrow indicates the containment, starting 
from the redundant module and ending in the bigger one. The three 
sub-figures (a), (b), and (c) show the insertion of genes b and c, d, and 
a into the tree, respectively.
Figure 5 The final enumeration tree. The modules found by the 
enumeration algorithm (encircled by ellipses).
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(11663 EBV miRNA/human mRNAs) pairs. We analyzed
some characteristics of the putative target-binding asso-
ciation (for the human miRNA-mRNA pairs). Figure 6(a)
shows the distribution of the number of target mRNAs
per each human miRNA, and Figure 6(b) shows distribu-
tion of the number of human miRNAs targeting each
mRNA. According to this analysis, one human miRNA
binds putatively to the 3'UTR of 327 mRNAs on average
(4.5% of the total number of mRNAs in the dataset).
Alternatively, one mRNA is targeted by 39 human miR-
NAs on average (4.5% of the total number of human miR-
NAs in the dataset). An analysis of the efficiency of our
filter can be found in the Appendix Section.
The predicted modules and supporting evidence
In this stage we used the target prediction results from
the previous stage. The enumeration process was carried
out on 72 GO categories versus 8 Atlas conditions, result-
ing in 576 <A, C> pairs, where A denotes an Atlas condi-
tion and C denotes a GO category. We found 54 modules
that fulfilled the following quorum constraints, q1 = 2, q2
= 1, and had a p-value lower than the cutoff (obtained by
a sampling procedure for each such pair. See Methods for
details). Modules with fewer than two genes were filtered
out. The expression level threshold t was calculated for
each miRNA as the average expression among all the
Atlas conditions related to B cells. Among the GO catego-
ries tested in our experiment, there are dependent cate-
gories that contain the same genes. Among Atlas
conditions sometimes groups of expressed miRNAs over-
lap. In order to reduce the redundancy of the reported
modules we combined identical modules from different
GO categories and Atlas conditions. This procedure
resulted in 34 modules. Below we present and analyze
two selected modules that were found by our method.
The full set of potential modules can be obtained at http:/
/www.cs.bgu.ac.il/~vaksler/BiTargeting.htm.
Module I( see Figure 7(a)) was obtained from genes
related to "induction of apoptosis" and miRNAs that are
expressed in Burkitt lymphoma. The module consists of
three human miRNAs, miR-17, miR-20a, and miR-15b,
one viral miRNA, miR-BART5, and three human genes.
A thorough literature search supported our predictions
as follows. miR-17 and miR-20a belong to the genomic
cluster miR-17-92. The cluster consists of six miRNAs
that are tightly grouped within an 800 base-pair region of
human chromosome 13 [50]. The miR-17-92 cluster first
attracted attention following a series of observations link-
ing these miRNAs to cancer pathogenesis, as it undergoes
amplification in several types of lymphoma and solid
tumors. It was also shown that these miRNAs are tightly
linked to the functions of the E2F family of transcription
factors, which are critical regulators of the cell cycle and
apoptosis. Furthermore, O'Donnell et al. [51] validated
that E2F1 is a target of miR-17 and miR-20a. Therefore,
these miRNAs lead to decreased E2F1 protein and thus
attenuate E2F induced apoptosis (see Figure 8).
The third human miRNA is miR-15b. This miRNA was
recently shown to regulate cell cycle progression in
glioma cells by targeting cell cycle-related genes, such as
CCNE1 [52]. In addition, Cimmino et al. [53] reported
that its analog miR-15a (along with miR-16-1) negatively
regulates BCL2, which is an anti-apoptotic gene that is
often overexpressed in many types of human cancers.
The participation of this miRNA in this module suggests
that this miRNA may also have oncogenic roles in this
particular type of malignancy, by targeting genes that
promote apoptosis.
The viral miRNA miR-BART5 was shown to target a
human protein PUMA [54]. PUMA plays a role in apop-
tosis as a direct downstream target of p53, in addition to
being able to initiate apoptosis via a p53-independent
mechanism [55]. Down-regulation of PUMA by miR-
BART5 may protect EBV-infected cells from virus-
induced apoptosis. Furthermore, searching for targets of
BART5 on the viral genome revealed 8 hits on the EBNA-
LP protein. EBNA-LP promotes the expression of viral
genes that expose the virus to the immune system.
Three human genes that were found to participate in
this module are strongly related to apoptosis. PPP1R13B
(also known as ASPP1) has an important function in cel-
lular apoptotic pathways [56,57]. ASPP1 and ASPP2
(another member of ASPP family) are induced by the
E2F1 transcription factor and cooperate with the tumor
suppressor p53 and its family members p63 and p73 in
trans-activating pro-apoptotic genes such as the BCL2-
family member BAX, the BCL2-binding component
PUMA, and p53-induced gene 3 (PIG3) (see Figure 8).
Inhibition of endogenous ASPP function suppresses the
apoptotic function of endogenous p53 in response to
apoptotic stimuli [57].
The second gene in the module is BCL2L11(also known
as BIM), which is a pro-apoptotic gene that regulates cell
death in mature B cells. It is thought to initiate apoptosis
by binding to and inactivating pro-survival BCL2-family
members, such as BCL2 [58]. Deletions or methylation of
the BIM locus are found in various human B lymphomas
[59,60]. Furthermore, it was shown previously that latent
infection of Burkitt Lymphoma cells with EBV results in a
significant reduction in the expression of BIM [61]. A
number of recent works ([62-64]) have also identified
BIM as a direct target of multiple members of the miR-
17-92 cluster (including mir-17 and miR-20a).
The third gene, TP63 (also known as p63), an impor-
tant epithelial developmental gene, is a member of the
p53 tumor-suppressor gene family. The p63 gene has two
promoters, resulting in two different types of proteins
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Figure 6 Characteristics of the human miRNAs/human mRNAs relationships. (a) Distribution of the number of target mRNAs per each miRNA. 
(b) Distribution of the number of miRNAs targeting each mRNA.
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Page 10 of 17with opposing functions, a p53-like protein containing
the TA domain (TAp63) and inhibitory proteins lacking
TA, called DNp63. TAp63 upregulates expression of
proapoptotic Bcl-2 family members such as Bax and
BCL2L11 [65]. p63 is capable of binding a series of p53-
responsive promoters and can transactivate many p53
target genes. p63 activity is regulated by proteins such as
ASPP1 and ASPP2 (see Figure 8), which also modulate
p53 activity. p63 can mediate apoptosis in a manner simi-
lar to that of p53, and it was proposed that p63 is essential
for p53-mediated apoptosis induced by DNA damage
[66]. The cooperative regulation of human and viral miR-
NAs of the apoptotic pathway is demonstrated in Figure
8. The dashed arrows indicate validated targets of miR-
17, mir-20a, and miR-BART5, and the solid arrows indi-
cate the new regulation pattern discovered in our mod-
ule. Our predictions may imply that miRNAs in this
module target genes along the cascade that leads to apop-
tosis. In particular, these results predict that a primary
function of miR-BART-5 may be to prevent p53 mediated
apoptosis by targeting different mRNA transcripts.
Module II (see Figure 7(b)) consists of miRNAs from
the Hodgkin Lymphoma cell line, hsa-miR-17, hsa-miR-
24, and ebv-miR-BART3, and genes from the "regulation
of lymphocyte activation" category - CDKN2A and
ICOSLG.
CDKN2A (also known as p16-INK4A) is a tumor sup-
pressor that binds to the complex of cyclin D1 and cyclin-
dependent kinase 4 to repress its ability to phosphorylate
the retinoblastoma protein, and consequently, blocks cell
cycle progression from G1 to S [67,68]. Inactivation of
this gene has been shown in a wide variety of human can-
cers as a consequence of mutation, homozygous muta-
tion, or promoter methylation [69-71]. In addition, it was
shown that EBV oncoprotein LMP1 blocks the expression
of CDKN2A, by promoting the CRM1-dependent
nuclear export of Ets2, which is an important transcrip-
tion factor for CDKN2A, thereby reducing the level of its
expression [72]. Furthermore, human miRNA miR-24,
which presents in this module, has been demonstrated to
promote cell growth through repression of this gene [73].
miR-17, in addition to its function in attenuating E2F
induced apoptosis (see module I), was shown to target
CDKN1A (also known as p21), a gene that functions as a
regulator of cell cycle progression at G1 [74].
The second gene found in module II is ICOSLG. This
gene is expressed on monocytes, dendritic cells, and B
cells and can be induced by inflammatory stimuli in
peripheral tissue. Binding to ICOSL delivers a co-stimula-
tory signal for T cell proliferation and cytokine secretion
[75,76]. Furthermore, this gene was shown to be impor-
tant in several immune responses against pathogenic
Figure 7 Two predicted modules. The length of the UTR is indicated 
in the parentheses near the gene name. The expression in the Atlas 
condition and the average expression among B cell conditions is indi-
cated in the parentheses under the miRNA name. The Atlas conditions: 
(a) has_Burkitt-DG-75: Burkitt lymphoma cell line established from a 
10-year-old boy, EBV+; (b) hsa_Hodgkin-L591: Hodgkin Lymphoma 
cell line, EBV+.
Figure 8 The function of Module I genes in cellular apoptotic 
pathways, and the cooperative role of human and viral miRNAs in 
this cascade. The dashed arrows indicate validated targets of the miR-
NAs, the solid arrows indicate the new regulation pattern discovered 
in our module (the figure is partially adopted from [56]).
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Page 11 of 17microorganisms such as bacteria, parasites and viruses
[77-79].
The two modules presented have a tight connection to
the function of the EBV, which establishes a long-term
latent infection in the host cells. Thus, it is reasonable to
assume that EBV will use its and the host's machinery,
including miRNAs, for downregulating genes that lead to
apoptosis or immune response. These modules supply
evidence of the cooperation between human and EBV
miRNAs in the task of preventing apoptosis, promoting
cell growth, and evading the immune response. It is
important to note that the target sites of the human and
viral miRNAs on the UTRs of the genes in this module
are different. Thus this cooperation, with multiple target
sites, can lead to an increased degree of translational
repression.
Discussion and Conclusions
miRNAs represent a class of molecules produced by both
viruses and their hosts that can benefit either the virus or
the host, depending on the particular interaction. Viral
miRNAs were discovered only recently, and functional
relationships between viruses and viral or host miRNAs
are only now beginning to be elucidated. A comprehen-
sive understanding of the entire landscape of the miRNA-
mediated host-virus interactions may uncover novel
pathways that promote or limit virus replication. In turn,
this knowledge may lead towards the development of
effective antiviral therapy and could help guide drug
design.
In this work we focused on the contribution of viral and
host miRNAs in regulating host genes, and thus in pro-
moting or inhibiting viral replication or life cycle. Our
method searches for modules of miRNAs (host and viral)
and their common host target genes that are involved in
similar biological processes.
Our method is related to bi-clustering methods that
have been used in various biological issues [34]. The bi-
clustering approach groups rows and columns simultane-
ously in a two-dimensional data matrix. Alternatively, a
data matrix can be viewed as a bipartite graph. Previous
works, dealing with module search, represent one set of
nodes as miRNAs and the second set as target mRNAs;
the edges represent target relations. Since in our problem,
the miRNAs are of two different sources (viral and
human), we cannot use the existing methods of bi-clus-
tering. Instead, our graph can be viewed as a two-sided
bi-partite graph, and the goal is to find two sided bi-
cliques.
In order to achieve this goal, we developed a new bi-
targeting algorithm. The algorithm constructs an enu-
meration tree of human genes that are targeted by the
same sets of miRNAs, and contains the modules at the
end of its construction. Due to the application of a branch
and bound technique, the algorithm is very efficient and
enables, within a practical time, enumeration of all possi-
ble modules.
Our method combines a variety of biological data
sources. Genomic sequences were used for the target pre-
diction task. Tissue context information was used to nar-
row the list of human genes to genes that are expressed in
the cells infected by the virus of interest (e.g. B cells in the
case of EBV). miRNA expression profiles (from the
miRNA atlas) and GO annotations enabled us to find
potential modules consisting of miRNAs co-expressed in
an Atlas condition (and have a potential to regulate coop-
eratively a group of genes) and genes with similar biologi-
cal function from a GO category. The combination of
several information sources in the task of module detec-
tion minimizes noise and errors accompanying each
information source, resulting in more reliable results.
In addition, we developed our own method for target
prediction, which extends the threshold all-against-all
algorithm. The method performs an efficient genome-
wide target prediction of all the miRNAs against all the
possible subsequences of a set of mRNAs. Our algorithm
was able to prune a large portion of the aligned trees by
utilizing the fact that the number of errors in the miRNA-
mRNA duplex is bounded by some threshold.
Note that the two methods we present in this paper are
independent. One can use our target prediction algo-
rithm as an efficient stand-alone target prediction sys-
tem. In addition, our module finding method can use any
source of target information, produced by any of the
existing target prediction tools, using different principles
of target recognition. The method can also be applied to
other viruses, as long as their miRNA expression profiles
are available (along with human miRNAs).
We applied our method to the discovery of modules
consisting of human and viral (EBV) miRNAs and human
genes. The identified modules display meaningful discov-
eries supported by the literature. Two of the modules are
analyzed in detail in this paper.
Since not much is known about the function of viral
miRNAs, finding modules that link the viral miRNAs and
the human miRNAs, might help in understanding the
role of viral miRNAs in viral infections. Thus the method
developed in this work can be of help to better under-
stand viral-induced diseases and the role that miRNAs
plays in them.
Appendix
Predicting miRNA targets: a filter based on error bounded 
complementarity
We perform a genome-wide target prediction of all the
miRNAs against all the possible subsequences of a set of
mRNAs in an efficient way. The method we propose
extends the threshold all-against-all alignment algorithm
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Page 12 of 17[37,38]. All-against-all alignment problems can be solved
using dynamic programming and suffix trees [37]. Sagot
used a variant of this problem to extract approximate
repeated motifs from a sequence or common motifs from
a set of sequences [38]. In this work we extend this idea to
the task of target prediction by using prefix trees (tries).
The trie data structure [80], τ, allows representation of
the miRNA/mRNA sequences in an efficient way. The
tree τ has the following properties: each edge of τ repre-
sents a character c 8 {A, C, G, T/U}, the characters repre-
sented by sibling edges are distinct, and the
concatenation of the labels of the edges on a path from
the root to a leaf represents the full string inserted in the
tree.
For our target prediction system we construct two tries,
one for the miRNA sequences and one for sequence seg-
ments of the (reversed) mRNAs. Next, we apply the
branch and bound algorithm to find complementarities
between sequences from the miRNA trie and the mRNA
tries. In more detail, construction of the tries is as fol-
lows.
Let M be a set of m miRNAs, and let G denote a set of n
mRNA sequences in the database for the organism under
consideration. Consider the trees in Figure 9, τM and τG,
which represent the miRNA and mRNA sequences,
respectively. τM is built from the miRNA sequences in 5' T
3' orientation. A node u in τM keeps the character of the
incoming edge (the empty character in the root). A leaf
node, which corresponds to an miRNA, keeps in addition
a boolean vector V (u) initialized with F (for false). Each V
(u) has n cells, one for each mRNA, and each mRNA has
a running number. Cell i in V (u) indicates whether the
i'th mRNA is the miRNA's predicted target (V (u) [i] = T).
τG is built from mRNA subsequences, which are pro-
duced by partitioning the mRNA reversed (3' T 5')
sequences into given size consecutive overlapping win-
dows with a slide of 1-nt. The partitioning of the mRNA
into windows ensures that every nucleotide in the mRNA
will be examined as a potential starting point of a target
site to one or more miRNAs. Since the mRNA sequence
may have bulges when hybridized to an miRNA, we set
the size of the window to be longer than the typical
miRNA length, namely to 30 nucleotides. Each node in τG
keeps the same data as τM . It also has a list of all mRNAs
for which the path from the root of τG to this node spells a
substring of this mRNA (see Figure 9(b)).
Our goal now is to measure the complementarity
between all the miRNAs in τM and the mRNA subse-
quences in τG. In order to get an admissible branch-and-
bound search, we use a target prediction score which is
monotonic with respect to the increasing length of the
prefixes of the compared miRNAs and mRNAs (see Fig-
ure 10). The score, which is denoted by min_err(u, v) is
computed using dynamic programming.
The dynamic programming table DP
for any pair of nodes (u, v), u 8 τM, and v 8 τG, DP [u, v]
holds the target prediction score between the prefix of the
(miRNA) sequence spelled by the path from the root of τM
to node u versus the prefix of the (mRNA) sequence spelled
by the path from the root of τG to node v, respectively.
Let u' be the parent of node u in τM and let α be the
character labeling the edge between them. Similarly, let v'
be the parent of v in τG and let β be the character labeling
the edge between them. If we traverse the trees in pre-
order traversal, then (u', v'), (u', v), and (u, v') are com-
puted before (u, v).
The target prediction score of (u, v) is computed using
the recurrence formula given below:
where miRNA_gap and mRNA_gap are penalties for
inserting a gap on the miRNA side of the duplex or on the
mRNA side of the duplex, respectively, and match(α, β) is
the dis-complementarity penalty between the characters
α and β (equal to 0 if α and β are complementary, and a
positive score otherwise).
Note that mismatches and gaps increase min_err. Using
the restrictions on miRNA target detection based on
sequence complementarity, we can bound min_err with a
threshold k. Thus, an mRNA sequence T has a chance of
being a target of miRNA sequence P if min_err of P and T
is at most k.
Observation
The score min_err(u, v) is monotone with respect to an
increase in the prefix length of P and T (see k and k' in Fig-
ure 10).
Several features that are related to the hybridization
pattern between the miRNA and its targets are incorpo-
rated into this algorithm. There is an option (a) to require
a seed of a given length and position (perfect comple-
mentarity region) in the hybridization between the
miRNA and the mRNA, (b) to restrict the number of GU
pairs that are formed in the duplex, and (c) to restrict the
size of each bulge formed in the duplex. The thresholds
that we use for these features in our work are derived
from the literature describing experimentally verified
miRNA targets (see the Results Section).
The computation of min_err(u, v) is done in pre-order
traversal of the trees. Pruning is performed while travers-
ing the mRNA trie. The calculation is stopped at each
min err u v min
min err u v miRNA gap
min err u v mR_ ,
_ , _
_ ,( ) =
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Page 13 of 17node v of τG where min_err(u, v) >k, or one of the above
listed restrictions is violated. When the algorithm reaches
a leaf u in τM, it updates V (u) according to the mRNA
sequences that are located in the non-pruned nodes of τG.
At this point a hybridization structure between the
miRNA represented by leaf u and the corresponding
mRNA target sequences is calculated using the RNAdu-
plex program [39]. Duplexes with a normalized free
energy score (i.e., the duplex energy normalized by the
energy score of the miRNA bound to its perfect comple-
ment) less than a given user threshold are filtered. After
performing the DP, we are left with an miRNA tree where
every leaf node v is associated with the set of mRNAs
which are its predicted targets, as maintained in the T(v)
vector.
We note that the filter described in this section is
stand-alone, and can be used independently on other spe-
cies with different parameters.
Filter efficiency measurements
We demonstrate the efficiency of applying our filter on
the dataset, described in the Datasets subsection, with
three sets of parameters as detailed in Table 4. Each UTR
was partitioned into sliding windows of size 30 nts, with a
Figure 9 The prefix tries. (a) τM and (b) τG, miRNA and mRNA tries, respectively.
Figure 10 min_err monotonicity property. The score min_err(u, v) is monotone with respect to the increase in the prefix length of the miRNA and 
mRNA sequences.
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7356844 subsequences. Since the RNAduplex procedure
is by far the most time consuming component of our
method, we measured the efficiency of our filter in terms
of the number of calls to RNAduplex.
We define by the naive method a method that calls
RNAduplex when there is a seed complementarity, under
the constraints of seed location and number of GU pairs
in the seed (see columns 1 and 2 in Table 4). Columns (A)
and (B) contain the number of RNAduplex calls for the
naive method and for our method, respectively, and col-
umn (C) contains the percent of calls saved by our
method.
In all three data sets there is a great reduction in the
number of RNAduplex calls. The middle row demon-
strates a much bigger save in number of calls by our
method. This is mainly because of the strong constraint
applied on the number of allowed errors (column 6). The
reduction in the number of calls to RNAduplex is due to
the compression of the sequences of both miRNAs and
mRNAs into prefix trees and the strong pruning that we
apply during the calculation of the hybridization score,
accompanied with the constraints that we apply on
potential duplexes.
Hypergeometric p-value
For a given module obtained for a pair <A, C>, the hyper-
geometric p-value is computed as follows: Let n be the
total number of genes in the dataset and c the number of
genes that belong to the GO category C (denoted as N
and C in Figure 3, respectively). Let t be the number of
mutual targets of the miRNAs in the module and tc the
number of genes among them that also belong to C (the
latter is the result of the enumeration algorithm). The
hypergeometric p-value of this module is:
Pseudocode of the enumeration algorithm
input : Genes - list of genes from a certain GO category.
Every gene x in this list has a set of human and viral miR-
NAs targeting it, denoted as x.h_miRs and x.v_miRs,
respectively.












Algorithm 1: construct tree
input : gene - a new gene to be inserted into the tree
input : root - the root node of the enumeration tree
input : q1, q2 - quorum restriction on human and viral
miRNAs
output: Creates a new node and appends to it (as its
children) all its siblings
node = new Node(gene);
foreach child 8 root:children do
sibling$ copy(child);
foreach leaf 8 sibling:leaves do
size1$ leaf.h_miRs.size;



































Table 4: The efficiency of the filter on three different sets of parameters.
Constraints (A) RNAduplex calls 
in the naive method






No. of GU pairs Maximal bulge size
in seed total on miRNA on mRNA Maximal no. 
of errors
2-8 1 4 6 6 6 1819306 1108226 39%
2-8 1 2 6 6 3 1819306 140920 92%
2-7 0 4 6 6 6 480099 267087 45%
Veksler-Lublinsky et al. BMC Bioinformatics 2010, 11:249
http://www.biomedcentral.com/1471-2105/11/249
Page 15 of 17leaf.h_miRs$ Intersect(leaf.h_miRs, gene.h_miRs);
size2$ leaf.v_miRs.size;
leaf.v_miRs$ Intersect(leaf.v_miRs; gene.v_miRs);
if size(leaf.h_miRs) == size1 and size(leaf.v_miRs)
== size2 then
/* Delete due to the
containment */
Delete the path from the leaf in child subtree;
end
if leaf.h_miRs.size < q1 or leaf.v_miRs.size < q2
then
/* Prune due to the quorum
restrictions */
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